More on DARE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+42.9% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Dare Bioscience (NQ:DARE)
Delayed: 0.71 -0.01 (1.39%)
Prev. Close $0.72  
Open$0.70 
52 Wk High$ 
52 Wk Low$ 
Day High$0.72 
Day Low$0.70 
P/E N/A  
EPS$ 
Volume103,439 


Aug 31, 2026 08:44 AM Daré Bioscience gets $908K NIH grant for preterm birth program
Aug 31, 2026 08:44 AM Daré Bioscience Announces New NIH Funding Award for Approximately $908,000 to Advance DARE-PTB2 for the Prevention of Preterm Birth
Aug 28, 2026 04:01 PM Form SCHEDULE 13G Dare Bioscience, Inc. Filed by: Lind Global Fund III LP
Aug 27, 2026 09:01 AM Daré Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor “Why Now” On-Demand Series
Aug 26, 2026 05:16 PM Form S-1 Dare Bioscience, Inc.
Aug 26, 2026 08:45 AM Daré Bioscience publishes sildenafil cream Phase 1 data in menopause journal
Aug 26, 2026 08:45 AM Daré Bioscience’s Sildenafil Cream Data in Postmenopausal Women Published in Menopause - The Journal of The Menopause Society
Aug 25, 2026 08:55 AM Daré Bioscience CEO discusses pipeline and commercial shift
Aug 25, 2026 08:55 AM Daré Bioscience CEO Outlines Commercial Transformation, Pipeline Momentum and Potential Key Catalysts in Virtual Investor CEO Connect Segment
Aug 24, 2026 04:10 PM Form SCHEDULE 13G Dare Bioscience, Inc. Filed by: L1 Capital Global Opportunities Master Fund, Ltd.
View All Articles

Entities mentioned with DARE

View All Entities